- Home
- MRNA vs CHRW Comparison
MRNA vs CHRW Comparison
Compare MRNA & CHRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- CHRW
- Stock Information
- Founded
- MRNA 2010
- CHRW 1905
- Country
- MRNA United States
- CHRW United States
- Employees
- MRNA N/A
- CHRW N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- CHRW Oil Refining/Marketing
- Sector
- MRNA Health Care
- CHRW Consumer Discretionary
- Exchange
- MRNA Nasdaq
- CHRW Nasdaq
- Market Cap
- MRNA 10.6B
- CHRW 10.7B
- IPO Year
- MRNA 2018
- CHRW 1997
- Fundamental
- Price
- MRNA $24.25
- CHRW $88.97
- Analyst Decision
- MRNA Hold
- CHRW Buy
- Analyst Count
- MRNA 20
- CHRW 19
- Target Price
- MRNA $51.94
- CHRW $114.39
- AVG Volume (30 Days)
- MRNA 8.5M
- CHRW 1.3M
- Earning Date
- MRNA 05-01-2025
- CHRW 04-30-2025
- Dividend Yield
- MRNA N/A
- CHRW 2.79%
- EPS Growth
- MRNA N/A
- CHRW 64.94
- EPS
- MRNA N/A
- CHRW 4.19
- Revenue
- MRNA $3,177,000,000.00
- CHRW $17,359,385,000.00
- Revenue This Year
- MRNA N/A
- CHRW $0.79
- Revenue Next Year
- MRNA $11.16
- CHRW $4.29
- P/E Ratio
- MRNA N/A
- CHRW $21.24
- Revenue Growth
- MRNA N/A
- CHRW N/A
- 52 Week Low
- MRNA $23.15
- CHRW $78.16
- 52 Week High
- MRNA $170.47
- CHRW $114.82
- Technical
- Relative Strength Index (RSI)
- MRNA 38.02
- CHRW 42.97
- Support Level
- MRNA $23.70
- CHRW $86.58
- Resistance Level
- MRNA $28.52
- CHRW $90.01
- Average True Range (ATR)
- MRNA 1.36
- CHRW 2.34
- MACD
- MRNA -0.09
- CHRW 0.22
- Stochastic Oscillator
- MRNA 11.11
- CHRW 36.49
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About CHRW C.H. Robinson Worldwide Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (about 61% of net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm operates a large air and ocean forwarding division (27%), which has grown organically and via tuck-in acquisitions over the years. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.